Pfizer sees Covid-19 drug sales topping $50 billion in 2022
This post was originally published on this site Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation. Pfizer, whose vaccinee developed with German company...
Pfizer and BioNTech announce plans to test omicron-specific COVID-19 vaccine in adult trials
This post was originally published on this sitePfizer and BioNTech will conduct three simultaneous trials in adults to determine if an omicron-specific vaccine is more effective than current shots.
COVID–19 Vaccine Accountability Act would remove near-total legal immunity for Pfizer, Moderna…
This post was originally published on this siteCOVID–19 Vaccine Accountability Act would remove near-total legal immunity for Pfizer, Moderna, Johnson & Johnson Rep. Scott Perry (R-PA10) Should Americans be able to sue the companies which make the COVID-19 vaccine? Context During a public health emergency, the federal government wants to remove any barriers...
CDC Panel Considers Pfizer Boosters for 12- to 15-Year-Olds
This post was originally published on this siteAdolescents could gain access to the shots for the first time as the Omicron variant spreads through communities and threatens to disrupt schools trying to stay open.
‘Our best defense’: Pfizer says third dose of its COVID vaccine protects against omicron
This post was originally published on this siteA third dose of the Pfizer-BioNTech vaccine appears to be as effective against omicron as two doses were against the original variant.
Pfizer Says Vaccine Loses Effectiveness Against Omicron
This post was originally published on this sitePfizer and BioNTech said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.
- 1
- 2